Tower Research Capital (TRC)’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Tower Research Capital (TRC)’s Portfolio OCAT Stock Details OCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,678	Closed	-$14K	–	5522
2015 Q2	$14K	Buy	+2,678	New	+$17.2K	﹤0.01%	2441

Other funds holding OCAT

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Visium Asset Management New York $955M AUM 3.58% 1-Year Est. Return

Highland Capital Management (Texas) Dallas, Texas $39M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return